• Kumatomic@lemmy.dbzer0.com
    link
    fedilink
    arrow-up
    2
    ·
    7 months ago

    Exactly. It’s an argument for regulation. Also maybe they should spend some of their advertisement budget on R&D instead of convincing patients what they should be on.